Completed NA INTERVENTIONAL 1-arm NCT05207618

Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant

Utility of the Administration of Tannin Specific Natural Extract, Chesnut and Quebracho Based, for Irritable Bowel Syndrome Diarrhea Predominant

Sponsor: Hospital de Clinicas José de San Martín

Conditions Diarrhea Irritable Bowel Syndrome

Interventions ARBOX (QUEBRACHO AND CHESNUT EXTRACT)

Updated 4 times since 2022 Last updated: Jul 4, 2022 Started: Sep 21, 2021 Primary completion: Feb 20, 2022 Completion: Apr 20, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05207618, this NA trial focuses on Diarrhea and Irritable Bowel Syndrome and remains completed. Sponsored by Hospital de Clinicas José de San Martín, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2022 — Sep 2022 [monthly]

Recruiting NA

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital de Clinicas José de San Martín
SILVATEAM

Data source: Hospital de Clinicas José de San Martín

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Buenos Aires, Argentina